News archive

December 1, 2022
Q3 financial and operational update Lifecare AS will present Q3 2022 financial and operational status on Tuesday 6 December.   The webcast will be for all shareholders and interested parties at 13:00 – 14:00 CET. Lifecare CEO Joacim Holter will participate in the webcast. There will be a Q&A session following the presentation. The webcast will be available […]
Read more
November 8, 2022
Lifecare has incorporated a new subsidiary, Lifecare Chemistry Ltd, located in Bath, UK. – This move gives us clear strategic advantages related to chemical research development and builds on the close and good collaboration Lifecare already has established with the University of Bath, says CEO Joacim Holter.   Photo caption: Left to right: Jordan Gardiner, […]
Read more
October 7, 2022
Business presentation at LSX 2022 The LSX Nordic Congress is the leading senior executive strategy, investment and partnering conference for the Nordic region and took place in Copenhagen in September. – We register an increasing interest for the company on the Nordic investor scene, states CEO Joacim Holter.   – After a long period of pandemic, […]
Read more
October 4, 2022
Interim data analysis of the first in-human study shows that Lifecare’s sensor is able to monitor glucose variations. Conducting clinical trials on humans is a significant step towards Lifecare’s goal of contributing to helping people with diabetes to live a normal life.     The purpose of the first study is to optimize signal reading from the […]
Read more
August 8, 2022
Independent experts from the European Commission’s Innovation Radar have reviewed Lifecares technology in the EU funded project FORGETDIABETES. The review concludes that Lifecare’s innovations are “Market Ready” and considered among the top 14% of innovations in scientific projects receiving financial grants from the European Commission.   Lifecare is part of the EU funded research project […]
Read more
July 4, 2022
Lifecare achieved the two major milestones for 1H2022 in June and continue to strengthen the organization. It was a very important milestone for Lifecare to conclude successful, high-quality and reproduceable in-vitro test results with the fabricated Sencell sensor prototypes for the clinical trials on 2 June 2022: https://newsweb.oslobors.no/message/563975 Following this achievement, Lifecare continued the prototype […]
Read more
June 9, 2022
Lifecare has recently concluded successful in-vitro test results of the miniaturized Sencell sensor. This represents a milestone achievement of the Sencell development, and the impact of the in-vitro tests reaches even further. Learn more about the importance of these test results, as well as further increase of staff in the Lifecare Group, a nationwide press […]
Read more
May 4, 2022
For our development site in Reutlingen, Germany, we have an open position as: Technical research scientist / electrical engineer for Biomedical MEMS   Main responsibilities will be: Taking responsibility for the measurement techniques, mainly, programming and interfacing the readout devices at our facilities in Germany (Reutlingen). Investigating low noise instrumentation/devices, implementing, and testing them on […]
Read more
April 4, 2022
Demonstration of nano-scale dispensing of biochemical solutions on the Sencell chip and an article in the Norwegian Technical Weekly. Upcoming events and an operational update.  Read more below:   Nanofluidics and assembly The Sencell Glucose sensor is based on a pre-produced silicon chip where Lifecare in the first step applies nano-scale pressure sensors and microelectronics. […]
Read more
March 22, 2022
CEO Joacim Holter was interviewed by the Norwegian Magazine Teknisk ukeblad in March 2022. Read more here (Norwegian only): Norsk teknologi kan gjøre livet lettere for diabetikere – Tu.no
Read more